Week in review: Atropine microdose, errant injection, ocular COVID

This week, Bausch acquires a microdose formulation of atropine, an injection of hyaluronic acid leads to severe complications and researchers report SARS-CoV-2 antigens can linger in ocular tissues months after the infection has passed.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553